7th Meeting of the EASD Study Group on the Genetics of Diabetes [EASD-SGGD]
7th Meeting of the EASD Study Group on the Genetics of Diabetes [EASD-SGGD]

P01 Anni Antikainen GENOME-WIDE ASSOCIATION ANALYSIS ON CORONARY ARTERY DISEASE IN TYPE 1 DIABETES CONFIRMS CDKN2B-AS1 AND SUGGESTS BETA-DEFENSIN 127 AS A NOVEL RISK LOCUS
P02 Seth Sharp DEVELOPMENT AND STANDARDIZATION OF A TYPE 1 DIABETES GENETIC RISK SCORE FOR USE IN NEWBORN SCREENING AND INCIDENT DIAGNOSIS
P03 Erkka Valo THE ROLE OF RARE VARIANTS IN DIABETIC NEPHROPATHY IN INDIVIDUALS WITH TYPE 1 DIABETES
P04 Jani Haukka WHOLE GENOME SEQUENCING OF INDIVIDUALS WITH TYPE 1 DIABETES REVEALS SUGGESTIVE ASSOCIATIONS FOR DIABETIC NEPHROPATHY
MODY
P05 Jana Malíková FUNCTIONAL ANALYSES OF HNF1A-MODY VARIANTS REFINE INTERPRETATION OF IDENTIFIED SEQUENCE VARIANTS
P06 Alshafi Mohammad EXPLORING STRATEGIES TO DETECT MODY IN AN EMIRATI POPULATION
P07 Juraj Staník AGE OF DIABETES ONSET IN PATIENTS WITH MODY
P08 Terézia Valkovičkova HShS-CRP AS A BIOMARKER FOR HNF1A-MODY
P09 Jonathan Locke A LOWER BIRTH WEIGHT IS ASSOCIATED WITH INCREASED PENETRANCE OF HNF4A-MODY
P10 Yumeng Huang IMPAIRED PROINSULIN OXIDATIVE FOLDING AND INTRACELLULAR TRAFFICKING CONTRIBUTE TO MODY CAUSED BY INSULIN GENE MUTATIONS
P11 Shivani Misra THE IMPACT OF ETHNICITY ON WOMEN IDENTIFIED FOR GLUCOKINASE MODY TESTING DURING PREGNANCY
P12 Magdalena Szopa THE UTILITY OF MODY PROBABILITY CALCULATOR IN POLISH PATIENTS WITH DIABETES
P13 Bente Berg Johansson PERSONALIZED MEDICINE IN DIABETES: UNRAVELING THE DISEASE CAUSALTY OF HNF1B GENE CODING VARIANTS IN TWO LARGE NORWEGIAN DIABETES REGISTRIES
Monogenic diabetes
P14 Shenali Amaratnga RARE GENETIC CAUSES OF DIABETES IN CONSANGUINNEOUS FAMILIES FROM IRAQ
P15 Martine Vaxillaire MONOGENIC DIABETES GENES SCREENING IN ELEVEN MEDITERRANEAN COUNTRIES: THE MGSD-MODY STUDY
P16 Cécile Saint-Martin CHROMOSOME 11 UPD REVEALED BY NGS SEQUENCING
P17 Rosa Martinez MONOGENIC DIABETES DETECTION IN A PAEDIATRIC SPANISH COHORT SUSPECTED OF TYPE 1 DIABETES AND NEGATIVE AUTOIMMUNITY
P18 Štěpánka Průhová CHARACTERISTICS OF MONOGENIC DIABETES REGISTERS WITHIN THE ENDO-ERN NETWORK
P19 Daniela Vejražková DYNAMICS OF GLUCOSE TOLERANCE IN RELATION TO RS10830963 OF THE MTNR1B GENE
Type 2 Diabetes and Metabolism
P20 David Galuška T2DM genetic risk
score and morbidity and mortality associated with diabetic kidney disease
P21 Anna Jonson GENOME WIDE ASSOCIATION STUDY OF CIRCULATING LEVELS OF GLUCOSE-DEPENDENT
INSULINOTROPIC POLYPEPTIDE AND GLUCAGON-LIKE PEPTIDE-1 DURING AN ORAL GLUCOSE
TOLERANCE TEST
P22 Hannah Maude FINE-MAPPING T2D RISK LOCI REVEALS ALLELIC HETEROGENEITY AND THE
POTENTIAL ROLE OF RARER VARIANTS IN REGULATING AMINO ACID AND FATTY ACID
CATABOLISM
P23 Koen Dekkers A GENETIC PREDISPOSITION TO KNOWN RISK FACTORS FOR TYPE 2 DIABETES
AFFECTS TOLERANCE TEST RESPONSE CURVES AND RESPONSE CURVE PROGRESSION IN PEOPLE
WITH (PRE)DIABETES
P24 Robert Wagner Interaction between genetic diabetes risk and
pancreatic fat secretion in genetically predisposed individuals
P25 Mette Andersen A COMMON INTERGENIC VARIANT ON CHROMOSOME 11 ASSOCIATES WITH A FAVORABLE
METABOLIC PHENOTYPE IN GREENLANDERS
P26 Josef Včelák NME7 GENE IS ASSOCIATED WITH GLUCOSE LEVELS DURING ORAL GLUCOSE
TOLERANCE TEST
P27 Suzanne Jacobs SLC16A11 DISRUPTION IN VIVO CAUSES PHYSIOLGOCIAL CHANGES ASSOCIATED WITH
T2D PATHOGENESIS
P28 Rashimi Prasad B SIGNATURES OF FETAL PROGRAMMING IN CORD BLOOD FROM MOTHERS WITH
GESTATIONAL DIABETES MELLITUS DURING EARLY PREGNANCY
P29 Yanina Timasheva GENETICS OF TYPE 2 DIABETES, METABOLIC AND BLOOD PRESSURE TRAITS
HIGHLIGHTS SHARED BIOLOGICAL PATHWAYS
P30 Vicky Au Yeung UNDERSTANDING THE METABOLIC PATHWAYS LINKING WEIGHT GAIN AND TYPE 2
DIABETES RISK
P31 Nikolas Miniatis Population-specific genetic maps can effectively
integrate risk loci with omics data and provide important insights into the
genetic architecture of T2D
P32 Martin Javorský GLP1R GENE VARIANT IS ASSOCIATED WITH GLYCEMIC RESPONSE TO
TREATMENT WITH DPP-4 INHIBITORS
P33 Tanja Dujic TCF7L2 GENE VARIANT AND RESPONSE TO METFORMIN IN PATIENTS WITH TYPE 2
DIABETES
Obesity
P34 Haniej Yaghootkar “Favourable adiposity” genetic factors pinpoint
to the role of subcutaneous adipose tissue and ectopic liver fat in the ethnic
differences in adiposity and diabetes risk
P35 Jan Hubáček FTO, TCF7L2 AND CDKN2A/2B VARIANTS WITHIN THE CZECH AND ROMA/GYPSY
POPULATIONS
P36 Ondřej Šeda GENETICAL GENOMICS OF METABOLIC SYNDROME IN RECOMBINANT INBRED SET OF
RAT MODELS
P37 Hedvika Tůmová SCREENING OF GENETIC VARIANTS IN CHILDREN SUSPECTED OF MONOGENIC OBESITY
P38 Edrina Mujica IDENTIFICATION OF ALLELIC VARIANTS IN MC4R AND FTO AND THEIR ASSOCIATION
WITH OBESITY IN A VENEZUELAN POPULATION
P39 Andy R. Wood MISALIGNMENT OF CHRONOTYPE GENETICS AND SLEEP TIMING IS ASSOCIATED WITH
OBESITY

LOOKING FORWARD TO

MEETING YOU IN PRAGUE
12
Months
9
Days
1
Hours